Results of a Randomized, Double-Masked, Placebo-Controlled Phase 1/2 Study of a TRPV1 Antagonist SJP-0132 in Participants With Dry Eye Disease.
Saved in:
| Title: | Results of a Randomized, Double-Masked, Placebo-Controlled Phase 1/2 Study of a TRPV1 Antagonist SJP-0132 in Participants With Dry Eye Disease. |
|---|---|
| Authors: | Wada T; From the Research and Development Division, Senju Pharmaceutical Co., Ltd. (T.W., K.O.), Osaka, Japan., Omatsu K; From the Research and Development Division, Senju Pharmaceutical Co., Ltd. (T.W., K.O.), Osaka, Japan. Electronic address: k-omatsu@senju.co.jp., Pflugfelder SC; Baylor College of Medicine (S.C.P.), Houston, Texas, USA. |
| Source: | American journal of ophthalmology [Am J Ophthalmol] 2026 Apr; Vol. 284, pp. 216-225. Date of Electronic Publication: 2026 Jan 17. |
| Publication Type: | Journal Article; Randomized Controlled Trial; Clinical Trial, Phase I; Clinical Trial, Phase II |
| Journal Info: | Publisher: Elsevier Science Country of Publication: United States NLM ID: 0370500 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1879-1891 (Electronic) Linking ISSN: 00029394 NLM ISO Abbreviation: Am J Ophthalmol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 41554419 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Results of a Randomized, Double-Masked, Placebo-Controlled Phase 1/2 Study of a TRPV1 Antagonist SJP-0132 in Participants With Dry Eye Disease. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Wada+T%22">Wada T</searchLink>; From the Research and Development Division, Senju Pharmaceutical Co., Ltd. (T.W., K.O.), Osaka, Japan.<br /><searchLink fieldCode="AU" term="%22Omatsu+K%22">Omatsu K</searchLink>; From the Research and Development Division, Senju Pharmaceutical Co., Ltd. (T.W., K.O.), Osaka, Japan. Electronic address: k-omatsu@senju.co.jp.<br /><searchLink fieldCode="AU" term="%22Pflugfelder+SC%22">Pflugfelder SC</searchLink>; Baylor College of Medicine (S.C.P.), Houston, Texas, USA. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%220370500%22">American journal of ophthalmology</searchLink> [Am J Ophthalmol] 2026 Apr; Vol. 284, pp. 216-225. <i>Date of Electronic Publication: </i>2026 Jan 17. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article; Randomized Controlled Trial; Clinical Trial, Phase I; Clinical Trial, Phase II – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Elsevier+Science%22">Elsevier Science </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>0370500 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1879-1891 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2200029394%22">00029394 </searchLink><i>NLM ISO Abbreviation: </i>Am J Ophthalmol <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=41554419 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1016/j.ajo.2026.01.009 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 216 Titles: – TitleFull: Results of a Randomized, Double-Masked, Placebo-Controlled Phase 1/2 Study of a TRPV1 Antagonist SJP-0132 in Participants With Dry Eye Disease. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Wada T – PersonEntity: Name: NameFull: Omatsu K – PersonEntity: Name: NameFull: Pflugfelder SC IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 04 Text: 2026 Apr Type: published Y: 2026 Identifiers: – Type: issn-electronic Value: 1879-1891 Numbering: – Type: volume Value: 284 Titles: – TitleFull: American journal of ophthalmology Type: main |
| ResultId | 1 |
